Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - PHAROS ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ADVANCED MEDICAL SOLUTIONS - Ordinary Shares
-
ITDock Expands MSP Documentation Platform With Self-Hosted Deployment and New Technician Workflow Tools
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Dubai attracts 14,600 applications for 23 places on global talent programme
-
S&K Roofing Launches Instant Online Roofing Estimates for Northeast Ohio Homeowners
-
South Padre Island Vacation Rental Report 2027: Rising Lodging Revenue, Regional Investment and Road-Trip Value Point to Continued Demand
-
Result of the auction of 2.00 per cent DGB 2028 and 2.25 per cent DGB 2035
-
San Francisco Speeding Ticket Attorney Adam Cohen Explains Fines, DMV Points, and Defense Options for California Drivers
-
Chicago Divorce Attorney Michael Ian Bender Highlights Privacy Strategies for High-Profile Divorce
-
Hudson Valley DWI Defense Attorney Randall F. Inniss Guides Physicians Through Medical License Protection After a DWI Arrest
-
Ocean County Estate Planning Attorney Christine Matus Outlines Essential Estate Planning Tools for New Jersey Families
-
Boston Truck Accident Attorney Dino M. Colucci Outlines Liability and Federal Regulations in 18-Wheeler Collisions
-
TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM's incentive program
-
EGFR Non Small Cell Lung Cancer Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Astrazeneca, Bridge Biotherapeutics, Sichuan Kelun Pharma
-
Diabetic Foot Ulcers Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience
-
Diabetic Retinopathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Tech
-
Deutsche Lufthansa AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
-
Inflammatory Bowel Disease Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | AbbVie, Janssen Pharma, Abivax, Morphic Therapeutic, Eli Lilly, Gilead
-
Degenerative Disc Disease Pipeline 2026: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Mesoblast, DiscGenics, Biosplice Therapeutics, BIOPHARM
-
Chronic Smell and Flavor Loss Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Cyrano Therapeutics
-
Neuroblastoma Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Y-mAbs Therapeutics, United Therapeutics Corp, EUSA Pharma, Clarity Pharma
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 06 10 2026] - (CGWL)
-
Krait Critical Minerals Appoints Dr. Thomas O'Rourke as Strategic Advisor
-
Liver Cancer Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
-
Focal Segmental Glomerulosclerosis Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Retrophin, AbbVie, AstraZeneca, Pfizer, Sanofi, Teva
-
Alpha Thalassemia Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | Forma Therapeutics, Genmedicon Biopharma, Bristol-Myers Squibb, Agios Pharma
-
Cerebral Palsy Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Neurocrine Biosciences, Teva Pharma, Bundang CHA Hospital, Jazz Pharma
-
Beyond Now launches agentic platform to power CSPs growth in the agentic economy
-
Gemcorp and Fonds Souverain Malagasy Announce Strategic Partnership to Support Investment in Madagascar
-
Real machining challenges take centre stage for Dormer Pramet at AMB 2026
-
Securonix Named to 2026 Fortune Future 120 for Long-Term Growth Potential
-
United Nations Spotlight Initiative launches Sync or Storm, a new interactive game to help prevent violence against women and girls before it starts
-
Metastatic Prostate Cancer Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
Metastatic Breast Cancer Clinical Trial Drug Development Pipeline Expands with Contributions from 100+ Key Companies | DelveInsight
-
Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
-
Metastatic Colorectal Cancer Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 150+ Leading Players Wheeling the Therapeutics Landscape
-
Structural Heart Devices Market Insights and Competitive Analysis: Growth Drivers, Segment Trends, and Regional Outlook Through 2034
-
Metastatic Melanoma Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
-
Idiopathic Membranous Nephropathy (IMN) Market Set to Grow from USD 130 Million in 2025 to USD 1,000 Million by 2036 as First Targeted Therapies AdvanceIdiopathic Membranous Nephropathy (IMN) Market
-
Neuropathic Pain Market Poised for Major Change Through 2032 as Pipeline Therapies AdvanceNeuropathic Pain Market
-
Non-Postoperative Pain Management Market is Projected to Grow by 2036 Owing to the Shift Toward Non-opioid Therapies and Advances in Rapid-Acting Pain Treatments | DelveInsight
-
What a Lincoln extended warranty does for your resale value when you sell privately
-
Psoriasis Market Outlook Through 2034: Growth Driven by Advances in Biologic and Oral Therapies
-
Complex Regional Pain Syndrome Market is Projected to Grow by 2036 Owing to Rising Chronic Pain Burden and Advances in Targeted Treatment Approaches | DelveInsight
-
Genome Editing Market to Grow at a CAGR of 13.19% Through 2032, Driven by Rising Genetic Disorders, Advancements in CRISPR Technologies, and Strategic Activities
-
Giant Cell Arteritis Market Set for Significant Growth Through 2034 Driven by Advancing Therapies, Rising Diagnosed Cases, and Expanding Treatment Landscape | DelveInsight
-
Rare NRG1 Fusion Market is Projected to Grow by 2034 Owing to the Advancement of Tumor-Agnostic Therapies and Precision Medicine | DelveInsight
-
Brain Cancer Market is Projected to Grow by 2036 Owing to the Emergence of Targeted Therapies and Novel Treatment Approaches | DelveInsight
